Carlos Vasquez-Rios - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Carlos Vasquez-Rios

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Cell Reports Methods|October 28, 2025

Single-cell multiomics data integration and generation with scPairingJeffrey Niu, Carlos Vasquez-Rios, Jiarui Ding

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2025

ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial CancerGillian Vandekerkhove, Andrew J Murtha, David C Müller, et al.

Nature Communications|February 27, 2026

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancerDavid C Müller, Andrew J Murtha, Jack V W Bacon, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Cell Reports Methods|October 28, 2025

Single-cell multiomics data integration and generation with scPairingJeffrey Niu, Carlos Vasquez-Rios, Jiarui Ding

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2025

ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial CancerGillian Vandekerkhove, Andrew J Murtha, David C Müller, et al.

Nature Communications|February 27, 2026

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancerDavid C Müller, Andrew J Murtha, Jack V W Bacon, et al.

Pageof 1